{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:13:54Z","timestamp":1793646834732,"version":"4.5.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03261-x","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T21:01:02Z","timestamp":1764190862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development and In Vivo Evaluation of QbD-Assisted Squalene-based Luliconazole Entrapped Ethosomal Gel for the Skin Fungal Infection"],"prefix":"10.1208","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0291-2981","authenticated-orcid":false,"given":"Taqdir","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6893-2971","authenticated-orcid":false,"given":"Akash","family":"Vikal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1606-2241","authenticated-orcid":false,"given":"Preeti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5377-1082","authenticated-orcid":false,"given":"Ghanshyam","family":"Das Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5857-2624","authenticated-orcid":false,"given":"Shubham","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-6622","authenticated-orcid":false,"given":"Balak","family":"Das Kurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"3261_CR1","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s13671-017-0192-7","volume":"6","author":"D Seth","year":"2017","unstructured":"Seth D, et al. Global burden of skin disease: inequities and innovations. Curr Dermatol Rep. 2017;6:204\u201310.","journal-title":"Curr Dermatol Rep"},{"issue":"2","key":"3261_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms5020032","volume":"5","author":"A K\u00fchbacher","year":"2017","unstructured":"K\u00fchbacher A, Burger-Kentischer A, Rupp S. Interaction of Candida species with the skin. Microorganisms. 2017;5(2):32.","journal-title":"Microorganisms"},{"key":"3261_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/bjbs.2023.11314","volume":"80","author":"SA Howell","year":"2023","unstructured":"Howell SA. Dermatopathology and the diagnosis of fungal infections. Br J Biomed Sci. 2023;80:11314.","journal-title":"Br J Biomed Sci"},{"key":"3261_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/jof3040057","author":"F Bongomin","year":"2017","unstructured":"Bongomin F, et al. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi. 2017. https:\/\/doi.org\/10.3390\/jof3040057.","journal-title":"J Fungi"},{"issue":"7","key":"3261_CR5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/s41577-022-00826-w","volume":"23","author":"MS Lionakis","year":"2023","unstructured":"Lionakis MS, Drummond RA, Hohl TM. Immune responses to human fungal pathogens and therapeutic prospects. Nat Rev Immunol. 2023;23(7):433\u201352.","journal-title":"Nat Rev Immunol"},{"key":"3261_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jof9111059","author":"AP Douglas","year":"2023","unstructured":"Douglas AP, et al. Outbreaks of fungal infections in hospitals: epidemiology, detection, and management. J Fungi. 2023. https:\/\/doi.org\/10.3390\/jof9111059.","journal-title":"J Fungi"},{"key":"3261_CR7","volume":"3","author":"GKK Reddy","year":"2022","unstructured":"Reddy GKK, Padmavathi AR, Nancharaiah YV. Fungal infections: pathogenesis, antifungals and alternate treatment approaches. Curr Res Microb Sci. 2022;3:100137.","journal-title":"Curr Res Microb Sci"},{"key":"3261_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.605644","volume":"11","author":"VL Burstein","year":"2020","unstructured":"Burstein VL, et al. Skin immunity to dermatophytes: from experimental infection models to human disease. Front Immunol. 2020;11:605644.","journal-title":"Front Immunol"},{"key":"3261_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11090957","author":"AE Moskaluk","year":"2022","unstructured":"Moskaluk AE, VandeWoude S. Current topics in dermatophyte classification and clinical diagnosis. Pathogens. 2022. https:\/\/doi.org\/10.3390\/pathogens11090957.","journal-title":"Pathogens"},{"issue":"2","key":"3261_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jof7020119","volume":"7","author":"E Bojang","year":"2021","unstructured":"Bojang E, et al. Immune sensing of Candida albicans. J Fungi. 2021;7(2):119.","journal-title":"J Fungi"},{"key":"3261_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.115007","author":"L Chen","year":"2023","unstructured":"Chen L, et al. Confronting antifungal resistance, tolerance, and persistence: advances in drug target discovery and delivery systems. Adv Drug Deliv Rev. 2023. https:\/\/doi.org\/10.1016\/j.addr.2023.115007.","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"3261_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9080445","volume":"9","author":"G Wall","year":"2020","unstructured":"Wall G, Lopez-Ribot JL. Current antimycotics, new prospects, and future approaches to antifungal therapy. Antibiotics. 2020;9(8):445.","journal-title":"Antibiotics"},{"issue":"11","key":"3261_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ph15111427","volume":"15","author":"MM Teixeira","year":"2022","unstructured":"Teixeira MM, et al. New antifungal agents with azole moieties. Pharmaceuticals. 2022;15(11):1427.","journal-title":"Pharmaceuticals"},{"issue":"1","key":"3261_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jof9010117","volume":"9","author":"KA Linder","year":"2023","unstructured":"Linder KA, Kauffman CA, Miceli MH. Blastomycosis: a review of mycological and clinical aspects. J Fungi. 2023;9(1):117.","journal-title":"J Fungi"},{"issue":"6","key":"3261_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/1203475417716362","volume":"21","author":"AK Gupta","year":"2017","unstructured":"Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment. J Cutan Med Surg. 2017;21(6):525\u201339.","journal-title":"J Cutan Med Surg"},{"issue":"8","key":"3261_CR16","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1080\/09205063.2021.1892471","volume":"32","author":"AK Garg","year":"2021","unstructured":"Garg AK, et al. Solubility enhancement, formulation development and antifungal activity of luliconazole niosomal gel-based system. J Biomater Sci Polym Ed. 2021;32(8):1009\u201323.","journal-title":"J Biomater Sci Polym Ed"},{"key":"3261_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/CE.S49629","volume":"9","author":"D Khanna","year":"2014","unstructured":"Khanna D, Bharti S. Luliconazole for the treatment of fungal infections: an evidence-based review. Core Evid. 2014;9:113\u201324.","journal-title":"Core Evid"},{"issue":"20","key":"3261_CR18","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2174\/1381612828666220623095743","volume":"28","author":"CK Babu","year":"2022","unstructured":"Babu CK, et al. Luliconazole topical dermal drug delivery for superficial fungal infections: penetration hurdles and role of functional nanomaterials. Curr Pharm Des. 2022;28(20):1611\u201320.","journal-title":"Curr Pharm Des"},{"issue":"6","key":"3261_CR19","doi-asserted-by":"publisher","first-page":"602","DOI":"10.2174\/1573407214666180717111419","volume":"15","author":"AK Mishra","year":"2019","unstructured":"Mishra AK, et al. Chemistry and pharmacology of luliconazole (imidazole derivative): a novel bioactive compound to treat fungal infection-a mini review. Curr Bioact Compd. 2019;15(6):602\u20139.","journal-title":"Curr Bioact Compd"},{"issue":"5","key":"3261_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2174\/1567201813666160520114436","volume":"14","author":"V Garg","year":"2017","unstructured":"Garg V, et al. Ethosomes and transfersomes: principles, perspectives and practices. Curr Drug Deliv. 2017;14(5):613\u201333.","journal-title":"Curr Drug Deliv"},{"key":"3261_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.101568","volume":"56","author":"A Sharma","year":"2020","unstructured":"Sharma A, et al. Squalene integrated NLC based gel of tamoxifen citrate for efficient treatment of psoriasis: a preclinical investigation. J Drug Deliv Sci Technol. 2020;56:101568.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"6","key":"3261_CR22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s11095-021-03053-5","volume":"38","author":"AC Paiva-Santos","year":"2021","unstructured":"Paiva-Santos AC, et al. Ethosomes as nanocarriers for the development of skin delivery formulations. Pharm Res. 2021;38(6):947\u201370.","journal-title":"Pharm Res"},{"key":"3261_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104595","volume":"82","author":"N Chauhan","year":"2022","unstructured":"Chauhan N, et al. Ethosomes: a novel drug carrier. Ann Med Surg. 2022;82:104595.","journal-title":"Ann Med Surg"},{"key":"3261_CR24","volume":"11","author":"AA Aljohani","year":"2023","unstructured":"Aljohani AA, et al. Binary ethosomes for the enhanced topical delivery and antifungal efficacy of ketoconazole. Open Nano. 2023;11:100145.","journal-title":"Open Nano"},{"issue":"3","key":"3261_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4103\/0110-5558.72415","volume":"1","author":"P Verma","year":"2010","unstructured":"Verma P, Pathak K. Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Technol Res. 2010;1(3):274\u201382.","journal-title":"J Adv Pharm Technol Res"},{"key":"3261_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17050583","author":"RM Almuqbil","year":"2025","unstructured":"Almuqbil RM, Aldhubiab B. Ethosome-based transdermal drug delivery: its structural components, preparation techniques, and therapeutic applications across metabolic, chronic, and oncological conditions. Pharmaceutics. 2025. https:\/\/doi.org\/10.3390\/pharmaceutics17050583.","journal-title":"Pharmaceutics"},{"issue":"10","key":"3261_CR27","first-page":"2321","volume":"6","author":"M Kumar","year":"2018","unstructured":"Kumar M, Shanthi N, Mahato AK. Qualitative and quantitative methods for determination of drug luliconazole. International Journal of Research in Advent Technology. 2018;6(10):2321\u20139637.","journal-title":"International Journal of Research in Advent Technology"},{"key":"3261_CR28","doi-asserted-by":"crossref","unstructured":"Ondieki ASK, Rathore KS, Development and characterization of topical gel containing deep eutectic mixture of luliconazole for topical drug delivery system. Methods. 2023;10(4):294\u2013302.","DOI":"10.18231\/j.ijpca.2023.049"},{"key":"3261_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e01688","author":"M Kumar","year":"2019","unstructured":"Kumar M, et al. Preparation of luliconazole nanocrystals loaded hydrogel for improvement of dissolution and antifungal activity. Heliyon. 2019. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01688.","journal-title":"Heliyon"},{"issue":"10","key":"3261_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102052","volume":"14","author":"J Yang","year":"2022","unstructured":"Yang J, et al. Development of a luliconazole nanoemulsion as a prospective ophthalmic delivery system for the treatment of fungal keratitis: in vitro and in vivo evaluation. Pharmaceutics. 2022;14(10):2052.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3261_CR31","doi-asserted-by":"publisher","first-page":"928","DOI":"10.5958\/0974-360X.2020.00175.4","volume":"13","author":"P Bhanu","year":"2020","unstructured":"Bhanu P, Sundararajan R. Spectrophotometric determination of Luliconazole in bulk and pharmaceutical dosage form. Res J Pharm Technol. 2020;13(2):928\u201332.","journal-title":"Res J Pharm Technol"},{"key":"3261_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2023.122098","volume":"383","author":"N Malviya","year":"2023","unstructured":"Malviya N, Prabakaran A, Alexander A. Comparative study on ethosomes and transferosomes for enhancing skin permeability of sinapic acid. J Mol Liq. 2023;383:122098.","journal-title":"J Mol Liq"},{"issue":"4","key":"3261_CR33","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/08982104.2019.1682602","volume":"30","author":"M Kaur","year":"2020","unstructured":"Kaur M, Singh K, Jain SK. Luliconazole vesicular based gel formulations for its enhanced topical delivery. J Liposome Res. 2020;30(4):388\u2013406.","journal-title":"J Liposome Res"},{"issue":"6","key":"3261_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13959","volume":"33","author":"S Baghel","year":"2020","unstructured":"Baghel S, et al. Luliconazole-loaded nanostructured lipid carriers for topical treatment of superficial tinea infections. Dermatol Ther. 2020;33(6):e13959.","journal-title":"Dermatol Ther"},{"issue":"1","key":"3261_CR35","first-page":"4942659","volume":"2021","author":"NA Alhakamy","year":"2021","unstructured":"Alhakamy NA, et al. Development, optimization, and evaluation of luliconazole nanoemulgel for the treatment of fungal infection. J Chem. 2021;2021(1):4942659.","journal-title":"J Chem"},{"key":"3261_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2023.113718","volume":"234","author":"Y Giri","year":"2024","unstructured":"Giri Y, et al. Development of microemulgel formulations with varied permeation enhancers for transungual delivery of luliconazole in onychomycosis management. Colloids Surf, B. 2024;234:113718.","journal-title":"Colloids Surf, B"},{"issue":"6","key":"3261_CR37","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1080\/13693780802541518","volume":"47","author":"H Koga","year":"2009","unstructured":"Koga H, et al. In vitro antifungal activities of luliconazole, a new topical imidazole. Med Mycol. 2009;47(6):640\u20137.","journal-title":"Med Mycol"},{"issue":"1","key":"3261_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/adt.2023.059","volume":"22","author":"G Singh","year":"2024","unstructured":"Singh G, Narang RK. Quality by design assisted development of Luliconazole transethosomes in gel for the management of Candida albicans infection. Assay Drug Dev Technol. 2024;22(1):1\u201317.","journal-title":"Assay Drug Dev Technol"},{"issue":"7","key":"3261_CR39","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.2174\/1567201818666201214145818","volume":"18","author":"E Bhargav","year":"2021","unstructured":"Bhargav E, Reddy YP, Koteshwara KB. Development and optimization of luliconazole nanostructured lipid carriers based gel by quality by design its skin distribution studies, dermatokinetic modeling & in-vitro and ex-vivo correlation. Curr Drug Deliv. 2021;18(7):1041\u201353.","journal-title":"Curr Drug Deliv"},{"issue":"4","key":"3261_CR40","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3390\/pharmaceutics12040346","volume":"12","author":"NA Alhakamy","year":"2020","unstructured":"Alhakamy NA, et al. Retracted: optimized Icariin phytosomes exhibit enhanced cytotoxicity and apoptosis-inducing activities in ovarian cancer cells. Pharmaceutics. 2020;12(4):346.","journal-title":"Pharmaceutics"},{"issue":"6-S","key":"3261_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.22270\/jddt.v12i6-S.5705","volume":"12","author":"S Mishra","year":"2022","unstructured":"Mishra S, Gupta RA. Formulation and evaluation of niosomal gel of antifungal luliconazole. J Drug Deliv Ther. 2022;12(6-S):47\u201354.","journal-title":"J Drug Deliv Ther"},{"key":"3261_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2020.105028","volume":"234","author":"A Mahmood","year":"2021","unstructured":"Mahmood A, et al. Luliconazole loaded lyotropic liquid crystalline nanoparticles for topical delivery: QbD driven optimization, in-vitro characterization and dermatokinetic assessment. Chem Phys Lipids. 2021;234:105028.","journal-title":"Chem Phys Lipids"},{"key":"3261_CR43","doi-asserted-by":"crossref","unstructured":"Sinhal APS, Wagh RDW, Formulation and Evaluation of Lipid-Based Nano Formulation of Luliconazole. 2023.","DOI":"10.21203\/rs.3.rs-3624878\/v1"},{"key":"3261_CR44","doi-asserted-by":"crossref","unstructured":"Singh G, Narang RK. Polymeric micelle gel with luliconazole: in vivo efficacy against cutaneous candidiasis in Wistar rats.\u00a0Naunyn-Schmiedeberg's Arch Pharmacol. 2024;397:7001\u20137015.","DOI":"10.1007\/s00210-024-03090-y"},{"key":"3261_CR45","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.4c01718","author":"MF Aldawsari","year":"2024","unstructured":"Aldawsari MF, Alam A, Imran M. Rutin-loaded transethosomal gel for topical application: a comprehensive analysis of skin permeation and antimicrobial efficacy. ACS Omega. 2024. https:\/\/doi.org\/10.1021\/acsomega.4c01718.","journal-title":"ACS Omega"},{"issue":"4","key":"3261_CR46","doi-asserted-by":"publisher","first-page":"316","DOI":"10.3109\/08982104.2014.999686","volume":"25","author":"Y Zhai","year":"2015","unstructured":"Zhai Y, et al. Ethosomes for skin delivery of ropivacaine: preparation, characterization and ex vivo penetration properties. J Liposome Res. 2015;25(4):316\u201324.","journal-title":"J Liposome Res"},{"issue":"8","key":"3261_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/gels9080626","volume":"9","author":"S Kumari","year":"2023","unstructured":"Kumari S, et al. Development of soft luliconazole invasomes gel for effective transdermal delivery: optimization to in-vivo antifungal activity. Gels. 2023;9(8):626.","journal-title":"Gels"},{"issue":"2","key":"3261_CR48","first-page":"52","volume":"13","author":"J Yallavula","year":"2023","unstructured":"Yallavula J, Mandava K, Madhav V. Design and evaluation of topical gel containing solid-lipid nanoparticles loaded with luliconazole. International Journal of Pharmacy Research & Technology (IJPRT). 2023;13(2):52\u201364.","journal-title":"International Journal of Pharmacy Research & Technology (IJPRT)"},{"issue":"5","key":"3261_CR49","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1007\/s13346-021-00986-7","volume":"12","author":"A Mahmood","year":"2022","unstructured":"Mahmood A, et al. Dermatokinetic assessment of luliconazole-loaded nanostructured lipid carriers (NLCs) for topical delivery: qbd-driven design, optimization, and in vitro and ex vivo evaluations. Drug Deliv Transl Res. 2022;12(5):1118\u201335.","journal-title":"Drug Deliv Transl Res"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03261-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03261-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03261-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:04:20Z","timestamp":1770314660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03261-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3261"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03261-x","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflict of interest was found.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The protocol was approved by the Institutional Animal Ethics Committee (IAEC) of ISF College of Pharmacy (ISFCP\/IAEC\/CCSEA\/Meeting No: 05\/2024\/Protocol No. 41).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal Experiments"}}],"article-number":"42"}}